Selected research
Market Analysis & Forecast
Global Immune System Supplements Market Analysis and Forecast 2026-2032
Market perspective
The global Immune System Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Immune System Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Immune System Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Immune System Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Immune System Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Immune System Supplements include USANA Health Sciences, Swisse, Suntory, PERFECT, INFINITUS, Herbalife Nutrition, GNC, Glanbia and China New Era Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Immune System Supplements, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Immune System Supplements, also provides the revenue of main regions and countries. Of the upcoming market potential for Immune System Supplements, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immune System Supplements revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immune System Supplements market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Immune System Supplements revenue, projected growth trends, production technology, application and end-user industry.
Immune System Supplements Segment by Company
USANA Health Sciences
Swisse
Suntory
PERFECT
INFINITUS
Herbalife Nutrition
GNC
Glanbia
China New Era Group
By-health
Blackmores
Bayer AG
Amway
Immune System Supplements Segment by Type
Liquid
Soft Gels/Pills
Powder
Immune System Supplements Segment by Application
Online Sales
Offline Sales
Immune System Supplements Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune System Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune System Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune System Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Immune System Supplements in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Immune System Supplements company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune System Supplements revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid
- Soft Gels/Pills
- Powder
Applications
- Online Sales
- Offline Sales
Companies covered
- USANA Health Sciences
- Swisse
- Suntory
- PERFECT
- INFINITUS
- Herbalife Nutrition
- GNC
- Glanbia
- China New Era Group
- By-health
- Blackmores
- Bayer AG
- Amway
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Immune System Supplements Market by Type
- 1.2.1 Global Immune System Supplements Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Liquid
- 1.2.3 Soft Gels/Pills
- 1.2.4 Powder
- 1.3 Immune System Supplements Market by Application
- 1.3.1 Global Immune System Supplements Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Online Sales
- 1.3.3 Offline Sales
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Immune System Supplements Market Dynamics
- 2.1 Immune System Supplements Industry Trends
- 2.2 Immune System Supplements Industry Drivers
- 2.3 Immune System Supplements Industry Opportunities and Challenges
- 2.4 Immune System Supplements Industry Restraints
3 Global Growth Perspective
- 3.1 Global Immune System Supplements Market Perspective (2021-2032)
- 3.2 Global Immune System Supplements Growth Trends by Region
- 3.2.1 Global Immune System Supplements Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Immune System Supplements Market Size by Region (2021-2026)
- 3.2.3 Global Immune System Supplements Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Immune System Supplements Revenue by Players
- 4.1.1 Global Immune System Supplements Revenue by Players (2021-2026)
- 4.1.2 Global Immune System Supplements Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Immune System Supplements Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Immune System Supplements Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Immune System Supplements Key Players Headquarters & Area Served
- 4.4 Global Immune System Supplements Players, Product Type & Application
- 4.5 Global Immune System Supplements Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Immune System Supplements Market CR5 and HHI
- 4.6.3 2025 Immune System Supplements Tier 1, Tier 2, and Tier 3
5 Immune System Supplements Market Size by Type
- 5.1 Global Immune System Supplements Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Immune System Supplements Revenue by Type (2021-2032)
- 5.3 Global Immune System Supplements Revenue Market Share by Type (2021-2032)
6 Immune System Supplements Market Size by Application
- 6.1 Global Immune System Supplements Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Immune System Supplements Revenue by Application (2021-2032)
- 6.3 Global Immune System Supplements Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 USANA Health Sciences
- 7.1.1 USANA Health Sciences Company Information
- 7.1.2 USANA Health Sciences Business Overview
- 7.1.3 USANA Health Sciences Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.1.4 USANA Health Sciences Immune System Supplements Product Portfolio
- 7.1.5 USANA Health Sciences Recent Developments
- 7.2 Swisse
- 7.2.1 Swisse Company Information
- 7.2.2 Swisse Business Overview
- 7.2.3 Swisse Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.2.4 Swisse Immune System Supplements Product Portfolio
- 7.2.5 Swisse Recent Developments
- 7.3 Suntory
- 7.3.1 Suntory Company Information
- 7.3.2 Suntory Business Overview
- 7.3.3 Suntory Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.3.4 Suntory Immune System Supplements Product Portfolio
- 7.3.5 Suntory Recent Developments
- 7.4 PERFECT
- 7.4.1 PERFECT Company Information
- 7.4.2 PERFECT Business Overview
- 7.4.3 PERFECT Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.4.4 PERFECT Immune System Supplements Product Portfolio
- 7.4.5 PERFECT Recent Developments
- 7.5 INFINITUS
- 7.5.1 INFINITUS Company Information
- 7.5.2 INFINITUS Business Overview
- 7.5.3 INFINITUS Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.5.4 INFINITUS Immune System Supplements Product Portfolio
- 7.5.5 INFINITUS Recent Developments
- 7.6 Herbalife Nutrition
- 7.6.1 Herbalife Nutrition Company Information
- 7.6.2 Herbalife Nutrition Business Overview
- 7.6.3 Herbalife Nutrition Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.6.4 Herbalife Nutrition Immune System Supplements Product Portfolio
- 7.6.5 Herbalife Nutrition Recent Developments
- 7.7 GNC
- 7.7.1 GNC Company Information
- 7.7.2 GNC Business Overview
- 7.7.3 GNC Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.7.4 GNC Immune System Supplements Product Portfolio
- 7.7.5 GNC Recent Developments
- 7.8 Glanbia
- 7.8.1 Glanbia Company Information
- 7.8.2 Glanbia Business Overview
- 7.8.3 Glanbia Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.8.4 Glanbia Immune System Supplements Product Portfolio
- 7.8.5 Glanbia Recent Developments
- 7.9 China New Era Group
- 7.9.1 China New Era Group Company Information
- 7.9.2 China New Era Group Business Overview
- 7.9.3 China New Era Group Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.9.4 China New Era Group Immune System Supplements Product Portfolio
- 7.9.5 China New Era Group Recent Developments
- 7.10 By-health
- 7.10.1 By-health Company Information
- 7.10.2 By-health Business Overview
- 7.10.3 By-health Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.10.4 By-health Immune System Supplements Product Portfolio
- 7.10.5 By-health Recent Developments
- 7.11 Blackmores
- 7.11.1 Blackmores Company Information
- 7.11.2 Blackmores Business Overview
- 7.11.3 Blackmores Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.11.4 Blackmores Immune System Supplements Product Portfolio
- 7.11.5 Blackmores Recent Developments
- 7.12 Bayer AG
- 7.12.1 Bayer AG Company Information
- 7.12.2 Bayer AG Business Overview
- 7.12.3 Bayer AG Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.12.4 Bayer AG Immune System Supplements Product Portfolio
- 7.12.5 Bayer AG Recent Developments
- 7.13 Amway
- 7.13.1 Amway Company Information
- 7.13.2 Amway Business Overview
- 7.13.3 Amway Immune System Supplements Revenue and Gross Margin (2021-2026)
- 7.13.4 Amway Immune System Supplements Product Portfolio
- 7.13.5 Amway Recent Developments
8 North America
- 8.1 North America Immune System Supplements Revenue (2021-2032)
- 8.2 North America Immune System Supplements Revenue by Type (2021-2032)
- 8.2.1 North America Immune System Supplements Revenue by Type (2021-2026)
- 8.2.2 North America Immune System Supplements Revenue by Type (2027-2032)
- 8.3 North America Immune System Supplements Revenue Share by Type (2021-2032)
- 8.4 North America Immune System Supplements Revenue by Application (2021-2032)
- 8.4.1 North America Immune System Supplements Revenue by Application (2021-2026)
- 8.4.2 North America Immune System Supplements Revenue by Application (2027-2032)
- 8.5 North America Immune System Supplements Revenue Share by Application (2021-2032)
- 8.6 North America Immune System Supplements Revenue by Country
- 8.6.1 North America Immune System Supplements Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Immune System Supplements Revenue by Country (2021-2026)
- 8.6.3 North America Immune System Supplements Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
9 Europe
- 9.1 Europe Immune System Supplements Revenue (2021-2032)
- 9.2 Europe Immune System Supplements Revenue by Type (2021-2032)
- 9.2.1 Europe Immune System Supplements Revenue by Type (2021-2026)
- 9.2.2 Europe Immune System Supplements Revenue by Type (2027-2032)
- 9.3 Europe Immune System Supplements Revenue Share by Type (2021-2032)
- 9.4 Europe Immune System Supplements Revenue by Application (2021-2032)
- 9.4.1 Europe Immune System Supplements Revenue by Application (2021-2026)
- 9.4.2 Europe Immune System Supplements Revenue by Application (2027-2032)
- 9.5 Europe Immune System Supplements Revenue Share by Application (2021-2032)
- 9.6 Europe Immune System Supplements Revenue by Country
- 9.6.1 Europe Immune System Supplements Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Immune System Supplements Revenue by Country (2021-2026)
- 9.6.3 Europe Immune System Supplements Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Netherlands
10 China
- 10.1 China Immune System Supplements Revenue (2021-2032)
- 10.2 China Immune System Supplements Revenue by Type (2021-2032)
- 10.2.1 China Immune System Supplements Revenue by Type (2021-2026)
- 10.2.2 China Immune System Supplements Revenue by Type (2027-2032)
- 10.3 China Immune System Supplements Revenue Share by Type (2021-2032)
- 10.4 China Immune System Supplements Revenue by Application (2021-2032)
- 10.4.1 China Immune System Supplements Revenue by Application (2021-2026)
- 10.4.2 China Immune System Supplements Revenue by Application (2027-2032)
- 10.5 China Immune System Supplements Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Immune System Supplements Revenue (2021-2032)
- 11.2 Asia Immune System Supplements Revenue by Type (2021-2032)
- 11.2.1 Asia Immune System Supplements Revenue by Type (2021-2026)
- 11.2.2 Asia Immune System Supplements Revenue by Type (2027-2032)
- 11.3 Asia Immune System Supplements Revenue Share by Type (2021-2032)
- 11.4 Asia Immune System Supplements Revenue by Application (2021-2032)
- 11.4.1 Asia Immune System Supplements Revenue by Application (2021-2026)
- 11.4.2 Asia Immune System Supplements Revenue by Application (2027-2032)
- 11.5 Asia Immune System Supplements Revenue Share by Application (2021-2032)
- 11.6 Asia Immune System Supplements Revenue by Country
- 11.6.1 Asia Immune System Supplements Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Immune System Supplements Revenue by Country (2021-2026)
- 11.6.3 Asia Immune System Supplements Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Immune System Supplements Revenue (2021-2032)
- 12.2 SAMEA Immune System Supplements Revenue by Type (2021-2032)
- 12.2.1 SAMEA Immune System Supplements Revenue by Type (2021-2026)
- 12.2.2 SAMEA Immune System Supplements Revenue by Type (2027-2032)
- 12.3 SAMEA Immune System Supplements Revenue Share by Type (2021-2032)
- 12.4 SAMEA Immune System Supplements Revenue by Application (2021-2032)
- 12.4.1 SAMEA Immune System Supplements Revenue by Application (2021-2026)
- 12.4.2 SAMEA Immune System Supplements Revenue by Application (2027-2032)
- 12.5 SAMEA Immune System Supplements Revenue Share by Application (2021-2032)
- 12.6 SAMEA Immune System Supplements Revenue by Country
- 12.6.1 SAMEA Immune System Supplements Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Immune System Supplements Revenue by Country (2021-2026)
- 12.6.3 SAMEA Immune System Supplements Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst